PEI/plasmid polyplexes transfected human skin cells to overexpress LL-37, with culture supernatants reducing Staphylococcus aureus growth by 95.8% — enabling antimicrobial skin substitutes.
95.8% bacterial growth reductionSupernatants from LL-37-transfected skin cells killed Staphylococcus aureus in vitro
What the researchers found
Linear PEI/pDNA polyplexes successfully transfected human keratinocytes and fibroblasts to overexpress LL-37, with supernatants reducing S. aureus growth by 95.8%.
Why it matters
Drug-resistant skin infections in wound patients have high mortality. Genetically engineering skin substitutes to produce their own antimicrobial peptides could provide continuous, localized infection defense.
The numbers in context
95.8% S. aureus growth reduction; polyplex sizes 400 nm (linear PEI) and 250 nm (branched PEI); surface charge +30 mV; N/P ratio 19
How the study worked
In-vitro study optimizing PEI polymer/pDNA polyplex formation for transfection of primary human keratinocytes and fibroblasts, measuring LL-37 expression and antimicrobial activity against S. aureus.
Who was studied
Primary human keratinocytes and fibroblasts
What this study cannot tell us
In-vitro proof of concept; cytotoxicity concerns with branched PEI; 3D skin substitute construction not yet demonstrated; in-vivo wound healing not tested; limited to one bacterial strain.
How to read the evidence
Preliminary in-vitro proof of concept with promising antimicrobial activity, but 3D tissue construction and in-vivo testing are needed.
When this study was published
Published in 2020; gene therapy approaches for antimicrobial wound management continue to evolve.
The bigger picture
This combines gene therapy, nanotechnology, and antimicrobial peptide biology to create self-defending skin substitutes — a convergent approach to a major clinical problem.
Questions still open
- Can these LL-37-overexpressing cells be incorporated into functional 3D skin substitutes?
- How long does LL-37 overexpression persist after transfection?
- Would this approach work against multi-drug-resistant bacteria including MRSA?
Common questions
Can skin substitutes fight infections?
What are polyplexes?
Read the original research
Polyplexes System to Enhance the LL-37 Antimicrobial Peptide Expression in Human Skin Cells.
Tissue engineering. Part A, 26(7-8), 400-410
Citation
Patiño Vargas, Maria Isabel; Mesa Cadavid, Mónica; Arenas Gómez, Claudia Marcela; Diosa Arango, Johnatan; Restrepo Múnera, Luz Marina; Becerra Colorado, Natalia Yiset. (2020). Polyplexes System to Enhance the LL-37 Antimicrobial Peptide Expression in Human Skin Cells.. Tissue engineering. Part A, 26(7-8), 400-410. https://doi.org/10.1089/ten.TEA.2019.0196